These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22354220)

  • 61. Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health.
    Sadovsky R; Brock GB; Gray M; Jensen PK; Gutkin SW; Sorsaburu S
    J Am Acad Nurse Pract; 2011 Jun; 23(6):320-30. PubMed ID: 21649775
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sildenafil citrate improves erectile function: a randomised double-blind trial with open-label extension.
    McVary KT; Kaufman J; Young JM; Tseng LJ
    Int J Clin Pract; 2007 Nov; 61(11):1843-9. PubMed ID: 17887993
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emergence and success of PDE5 inhibitors as effective therapy for erectile dysfunction.
    Manganiello V
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S1-3. PubMed ID: 15224126
    [No Abstract]   [Full Text] [Related]  

  • 64. [Pharmacotherapy for erectile dysfunction].
    Hu WL; Hu LQ
    Zhonghua Nan Ke Xue; 2005 Aug; 11(8):626-30. PubMed ID: 16138587
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Erectile dysfunction: the Viagra revolution.
    Harv Mens Health Watch; 2005 Apr; 9(9):1-6. PubMed ID: 18217258
    [No Abstract]   [Full Text] [Related]  

  • 66. [Lacunar stroke after sildenafil administration].
    Arboix A; Alsina M; Massons J
    Med Clin (Barc); 2007 Mar; 128(10):398-9. PubMed ID: 17386250
    [No Abstract]   [Full Text] [Related]  

  • 67. Optic atrophy after sildenafil use.
    Sowka JW; Neiberg MN; Vollmer LA
    Optometry; 2007 Mar; 78(3):122-8. PubMed ID: 17321461
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sildenafil may elevate melanoma risk.
    Grichnik JM
    Dermatol Ther; 2014; 27(5):313. PubMed ID: 25285874
    [No Abstract]   [Full Text] [Related]  

  • 69. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.
    Gökçe A; Halis F; Demirtas A; Ekmekcioglu O
    BJU Int; 2011 Apr; 107(8):1274-7. PubMed ID: 21929518
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Male lower urinary tract symptoms and sildenafil.
    Jackson G
    Int J Clin Pract; 2007 Nov; 61(11):1779. PubMed ID: 17935539
    [No Abstract]   [Full Text] [Related]  

  • 71. [A happiness pill for those with erectile dysfunctions].
    Niemi M
    Duodecim; 1998; 114(17):1673, 1675-6. PubMed ID: 11717772
    [No Abstract]   [Full Text] [Related]  

  • 72. Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men.
    Soler JM; Previnaire JG; Denys P; Chartier-Kastler E
    Spinal Cord; 2007 Feb; 45(2):169-73. PubMed ID: 16801935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Phosphodiesterase inhibitors: effectiveness and new applications].
    van Driel MF
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1613-6. PubMed ID: 16901064
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ["Real-life study presented. Healthy sexuality stabilizes self-confidence].
    MMW Fortschr Med; 2005 Feb; 147(7):59. PubMed ID: 18441587
    [No Abstract]   [Full Text] [Related]  

  • 75. Analysis of the efficacy and safety of sildenafil citrate in the geriatric population.
    Müller A; Smith L; Parker M; Mulhall JP
    BJU Int; 2007 Jul; 100(1):117-21. PubMed ID: 17552959
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [7. ESSM Congress in London. Satisfying sex life improves quality of life].
    MMW Fortschr Med; 2005 Feb; 147(7):58. PubMed ID: 18437875
    [No Abstract]   [Full Text] [Related]  

  • 77. [Oral sildenafil demonstrates the effectiveness and well tolerance in the treatment of patients with erectile dysfunction].
    Shang XJ; Huang YF
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):877-9. PubMed ID: 16333970
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction.
    Dunn ME; Althof SE; Perelman MA
    Int J Impot Res; 2007; 19(2):119-23. PubMed ID: 16738695
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effectiveness of sildenafil citrate in patients with erectile dysfunction and lower urinary system symptoms and the significance of asymptomatic inflammatory prostatitis.
    Eryildirim B; Aktas A; Kuyumcuoglu U; Faydaci G; Tarhan F; Ozgül A
    Int J Impot Res; 2010; 22(6):349-54. PubMed ID: 20981108
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study.
    Safarinejad MR; Taghva A; Shekarchi B; Safarinejad Sh
    Int J Impot Res; 2010; 22(5):325-35. PubMed ID: 20861846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.